Groeppel Manfred 4
4 · IMMUNIC, INC. · Filed Jul 22, 2020
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Groeppel Manfred
Chief Operating Officer
Transactions
- Sale
Common Stock
2020-07-21$15.62/sh−650$10,155→ 278,830 total(indirect: See footnote) - Sale
Common Stock
2020-07-20$14.44/sh−5,000$72,201→ 279,480 total(indirect: See footnote)
Footnotes (2)
- [F1]These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG.
- [F2]The Reporting Person is Director of Groeppel Investments UG (haftungsbeschrankt), which is the record holder of 278,830 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares.